157 related articles for article (PubMed ID: 24973099)
1. A pilot study of urine cytokines in ketamine-associated lower urinary tract symptoms.
Cheung RY; Lee JH; Chan SS; Liu DW; Choy KW
Int Urogynecol J; 2014 Dec; 25(12):1715-9. PubMed ID: 24973099
[TBL] [Abstract][Full Text] [Related]
2. Urine cytokines suggest an inflammatory response in the overactive bladder: a pilot study.
Tyagi P; Barclay D; Zamora R; Yoshimura N; Peters K; Vodovotz Y; Chancellor M
Int Urol Nephrol; 2010 Sep; 42(3):629-35. PubMed ID: 19784793
[TBL] [Abstract][Full Text] [Related]
3. Cytokine and Chemokine Concentration in the Tear of Patients with Age-Related Cataract.
Engelbrecht C; Sardinha LR; Rizzo LV
Curr Eye Res; 2020 Sep; 45(9):1101-1106. PubMed ID: 31928443
[TBL] [Abstract][Full Text] [Related]
4. Molecular correlates in urine for the obesity and prostatic inflammation of BPH/LUTS patients.
Tyagi P; Motley SS; Koyama T; Kashyap M; Gingrich J; Yoshimura N; Fowke JH
Prostate; 2018 Jan; 78(1):17-24. PubMed ID: 29080225
[TBL] [Abstract][Full Text] [Related]
5. Urinary cytokines/chemokines pattern in patients with painful bone metastases undergoing external beam radiotherapy experiencing pain flare.
Bushehri A; Chow E; Zhang L; Azad A; Vuong S; Pasetka M; Zhou M; Hird A; Dennis K; McDonald R; DeAngelis C
Ann Palliat Med; 2016 Apr; 5(2):107-15. PubMed ID: 27121738
[TBL] [Abstract][Full Text] [Related]
6. Urinary cytokines/chemokines after magnetic resonance-guided high intensity focused ultrasound for palliative treatment of painful bone metastases.
Bushehri A; Czarnota G; Zhang L; Hynynen K; Huang Y; Chan M; Chu W; Dennis K; Mougenot C; Coccagna J; Sahgal A; Chow E; DeAngelis C
Ann Palliat Med; 2017 Jan; 6(1):36-54. PubMed ID: 28209068
[TBL] [Abstract][Full Text] [Related]
7. Ketamine-associated urinary tract dysfunction: an underrecognized clinical entity.
Lai Y; Wu S; Ni L; Chen Z; Li X; Yang S; Gui Y; Guan Z; Cai Z; Ye J
Urol Int; 2012; 89(1):93-6. PubMed ID: 22710265
[TBL] [Abstract][Full Text] [Related]
8. Urine chemokines indicate pathogenic association of obesity with BPH/LUTS.
Tyagi P; Motley SS; Kashyap M; Pore S; Gingrich J; Wang Z; Yoshimura N; Fowke JH
Int Urol Nephrol; 2015 Jul; 47(7):1051-8. PubMed ID: 25924782
[TBL] [Abstract][Full Text] [Related]
9. A Novel Proteomics Approach to Identify Serum and Urinary Biomarkers and Pathways that Associate with Lower Urinary Tract Symptoms in Men and Women: Pilot Results of the Symptoms of Lower Urinary Tract Dysfunction Research Network (LURN) Study.
Helfand BT; Andreev VP; Siddiqui NY; Liu G; Erickson BA; Helmuth ME; Lutgendorf SK; Lai HH; Kirkali Z;
Urology; 2019 Jul; 129():35-42. PubMed ID: 30922973
[TBL] [Abstract][Full Text] [Related]
10. Urinary biomarkers in hydronephrosis.
Madsen MG
Dan Med J; 2013 Feb; 60(2):B4582. PubMed ID: 23461995
[TBL] [Abstract][Full Text] [Related]
11. Effect of Sacral Neuromodulation on Outcome Measures and Urine Chemokines in Interstitial Cystitis/Painful Bladder Syndrome Patients.
Peters KM; Jayabalan N; Bui D; Killinger K; Chancellor M; Tyagi P
Low Urin Tract Symptoms; 2015 May; 7(2):77-83. PubMed ID: 26663686
[TBL] [Abstract][Full Text] [Related]
12. Cytokine and chemokine tear levels in patients with uveitis.
Carreño E; Portero A; Herreras JM; García-Vázquez C; Whitcup SM; Stern ME; Calonge M; Enríquez-de-Salamanca A
Acta Ophthalmol; 2017 Aug; 95(5):e405-e414. PubMed ID: 27873479
[TBL] [Abstract][Full Text] [Related]
13. The Chinese version of the pelvic pain and urgency/frequency symptom scale: a useful assessment tool for street-ketamine abusers with lower urinary tract symptoms.
Ng CM; Ma WK; To KC; Yiu MK
Hong Kong Med J; 2012 Apr; 18(2):123-30. PubMed ID: 22477735
[TBL] [Abstract][Full Text] [Related]
14. A survey for ketamine abuse and its relation to the lower urinary tract symptoms in Taiwan.
Li CC; Wu ST; Cha TL; Sun GH; Yu DS; Meng E
Sci Rep; 2019 May; 9(1):7240. PubMed ID: 31076629
[TBL] [Abstract][Full Text] [Related]
15. Epidemiologic characteristics and risk factors in patients with ketamine-associated lower urinary tract symptoms accompanied by urinary tract infection: A cross-sectional study.
Liu W; Wu W; Wei Y; Wu J; Li T; Zhu Q; Ye L; Hong F; Gao Y; Yang J
Medicine (Baltimore); 2019 Jun; 98(23):e15943. PubMed ID: 31169717
[TBL] [Abstract][Full Text] [Related]
16. Urinary chemokines/cytokines are elevated in patients with urolithiasis.
Suen JL; Liu CC; Lin YS; Tsai YF; Juo SH; Chou YH
Urol Res; 2010 Apr; 38(2):81-7. PubMed ID: 20204339
[TBL] [Abstract][Full Text] [Related]
17. BDNF-ERK1/2 signaling pathway in ketamine-associated lower urinary tract symptoms.
Wang X; Peng B; Xu C; Gao Z; Cao Y; Liu Z; Liu T
Int Urol Nephrol; 2016 Sep; 48(9):1387-93. PubMed ID: 27165402
[TBL] [Abstract][Full Text] [Related]
18. [Ketamine-associated urinary tract damage].
Chen WH; Guan ZC
Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Aug; 43(4):636-9. PubMed ID: 21844983
[TBL] [Abstract][Full Text] [Related]
19. Risk Factors of Lower Urinary Tract Syndrome among Ketamine Users.
Chen IC; Lee MH; Chen WC; Hu TC; Lin HY
Low Urin Tract Symptoms; 2018 Sep; 10(3):281-286. PubMed ID: 28707385
[TBL] [Abstract][Full Text] [Related]
20. Urine Cytokine and Chemokine Levels Predict Urinary Tract Infection Severity Independent of Uropathogen, Urine Bacterial Burden, Host Genetics, and Host Age.
Armbruster CE; Smith SN; Mody L; Mobley HLT
Infect Immun; 2018 Sep; 86(9):. PubMed ID: 29891542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]